Published in Biotechnology (N Y) on August 01, 1993
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol (1996) 3.66
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J (1994) 2.09
Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol (1996) 2.07
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol (1996) 2.01
Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J Virol (1994) 1.75
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73
Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol (1999) 1.69
Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol Med (1996) 1.68
Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J Virol (1997) 1.42
Alphavirus Entry and Membrane Fusion. Viruses (2010) 1.31
Membrane protein lateral interactions control Semliki Forest virus budding. EMBO J (1994) 1.31
Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A (1999) 1.30
Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88. J Virol (2005) 1.30
Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol (1998) 1.30
The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J Virol (1997) 1.28
The oligomerization reaction of the Semliki Forest virus membrane protein subunits. J Cell Biol (1995) 1.26
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci U S A (1995) 1.21
Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts. J Virol (1994) 1.21
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat Protoc (2014) 1.16
Targeted in vivo expression of proteins in the calyx of Held. Pflugers Arch (2004) 1.14
Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. J Virol (1997) 1.13
Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol (2000) 1.12
Probing the functional equivalence of otoferlin and synaptotagmin 1 in exocytosis. J Neurosci (2011) 1.11
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. J Virol (1997) 1.06
Phosphorylation of the human T-cell leukemia virus type 1 transactivator tax on adjacent serine residues is critical for tax activation. J Virol (1999) 1.05
Viral alteration of cellular translational machinery increases defective ribosomal products. J Virol (2007) 1.00
PE2 cleavage mutants of Sindbis virus: correlation between viral infectivity and pH-dependent membrane fusion activation of the spike heterodimer. J Virol (2001) 1.00
Optimization of transient gene expression in mammalian cells and potential for scale-up using flow electroporation. Cytotechnology (1998) 0.99
Aura alphavirus subgenomic RNA is packaged into virions of two sizes. J Virol (1995) 0.98
Overexpression of membrane proteins in mammalian cells for structural studies. Mol Membr Biol (2012) 0.96
Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool. Clin Diagn Lab Immunol (2003) 0.94
High-efficiency Semliki Forest virus-mediated transduction in bovine adrenal chromaffin cells. Biochem J (1999) 0.94
Efficient multiplication of a Semliki Forest virus chimera containing Sindbis virus spikes. J Virol (1997) 0.93
Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate. Proc Natl Acad Sci U S A (1997) 0.92
Effect of the umami peptides on the ligand binding and function of rat mGlu4a receptor might implicate this receptor in the monosodium glutamate taste transduction. Br J Pharmacol (1999) 0.90
Recombinant protein production using the Semliki Forest Virus expression system. Cytotechnology (1997) 0.88
M-X-I motif of semliki forest virus capsid protein affects nucleocapsid assembly. J Virol (2001) 0.88
Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function. J Virol (1998) 0.88
Activation of the alphavirus spike protein is suppressed by bound E3. J Virol (2011) 0.87
The dynamic envelope of a fusion class II virus. E3 domain of glycoprotein E2 precursor in Semliki Forest virus provides a unique contact with the fusion protein E1. J Biol Chem (2008) 0.86
Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection. J Virol (2010) 0.86
Regulated expression of a Sindbis virus replicon by herpesvirus promoters. J Virol (1999) 0.84
Alphavirus-based vaccines. Viruses (2014) 0.84
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol J (2013) 0.84
In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs. J Virol (2010) 0.83
Effect of temperature on recombinant protein expression in Semliki Forest virus infected mammalian cell lines growing in serum- free suspension cultures. Cytotechnology (1998) 0.82
Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System. Cytotechnology (2000) 0.80
A new model to produce infectious hepatitis C virus without the replication requirement. PLoS Pathog (2011) 0.80
Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. J Gen Virol (2010) 0.80
Alphaviruses in gene therapy. Viruses (2015) 0.79
Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus. J Virol (2008) 0.78
Characterization of the human gonadotropin-releasing hormone receptor heterologously produced using the baculovirus/insect cell and the Semliki Forest virus systems. Cell Mol Neurobiol (1998) 0.77
Mobilization of full-length Semliki Forest virus replicon by retrovirus particles. J Virol (2006) 0.77
Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure. Neth Heart J (2007) 0.76
A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles. PLoS One (2013) 0.75
Lectin-mediated retention of p62 facilitates p62-E1 heterodimerization in endoplasmic reticulum of Semliki Forest virus-infected cells. J Virol (2003) 0.75
Safety aspects related to recombinant protein expression from Semliki Forest virus vectors. Cytotechnology (2001) 0.75
Oncolytic Alphaviruses in Cancer Immunotherapy. Vaccines (Basel) (2017) 0.75
Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo. Exp Brain Res (2004) 0.75
Improvements of DNA sequencing gels. Anal Biochem (1981) 11.20
Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins. Nature (1980) 8.07
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) (1991) 7.08
In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol (1991) 6.02
Cell-free synthesis and membrane insertion of mouse H-2Dd histocompatibility antigen and beta 2-microglobulin. Cell (1979) 4.72
The budding mechanisms of enveloped animal viruses. J Gen Virol (1980) 4.08
A subcloning strategy for DNA sequence analysis. Nucleic Acids Res (1980) 4.06
The capsid protein of Semliki Forest virus has clusters of basic amino acids and prolines in its amino-terminal region. Proc Natl Acad Sci U S A (1980) 3.26
Assembly of the Semliki Forest virus membrane glycoproteins in the membrane of the endoplasmic reticulum in vitro. J Mol Biol (1978) 3.16
Location of the spike glycoproteins in the Semliki Forest virus membrane. Proc Natl Acad Sci U S A (1974) 3.10
The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J Virol (1989) 3.09
Isolation and characterization of the membrane proteins of Semliki Forest virus. Virology (1974) 2.97
Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol (1992) 2.91
Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science (2000) 2.90
Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J Virol (1992) 2.60
Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells. J Cell Biol (1992) 2.51
Structure and assembly of alphaviruses. Curr Top Microbiol Immunol (1982) 2.47
Formation of the Semliki Forest virus membrane glycoprotein complexes in the infected cell. J Gen Virol (1980) 2.44
Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J (1993) 2.36
Oligomers of the cytoplasmic domain of the p62/E2 membrane protein of Semliki Forest virus bind to the nucleocapsid in vitro. J Virol (1990) 2.33
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry. J Cell Biol (1992) 2.26
Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol (1998) 2.20
The transmembrane segment of the human transferrin receptor functions as a signal peptide. EMBO J (1986) 2.18
Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor. J Virol (1991) 2.17
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid. Structure (1996) 2.12
Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J (1984) 2.10
Solubilization of the membrane proteins from Semliki Forest virus with Triton X100. J Mol Biol (1973) 2.09
A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J (1994) 2.09
Using recombinant DNA techniques to study protein targeting in the eucaryotic cell. Annu Rev Cell Biol (1985) 2.07
Expression of Semliki Forest virus proteins from cloned complementary DNA. I. The fusion activity of the spike glycoprotein. J Cell Biol (1983) 2.03
Fusion function of the Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor p62. J Virol (1990) 2.00
Nuclear localization of Semliki Forest virus-specific nonstructural protein nsP2. J Virol (1990) 1.99
Processing of the Semliki Forest virus structural polyprotein: role of the capsid protease. J Virol (1987) 1.96
Structure of C-terminal half of two H-2 antigens from cloned mRNA. Nature (1981) 1.90
cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. Proc Natl Acad Sci U S A (1981) 1.90
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology (Oxford) (2003) 1.83
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
Cosmid cloning and transposon mutagenesis in Salmonella typhimurium using phage lambda vehicles. Mol Gen Genet (1981) 1.80
Contrasting developmental and tissue-specific expression of alpha and beta thyroid hormone receptor genes. EMBO J (1990) 1.79
A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Biotechnology (N Y) (1994) 1.78
Mutants of the membrane-binding region of Semliki Forest virus E2 protein. I. Cell surface transport and fusogenic activity. J Cell Biol (1986) 1.77
Exocytotic pathways exist to both the apical and the basolateral cell surface of the polarized epithelial cell MDCK. Cell (1985) 1.76
Foreign transmembrane peptides replacing the internal signal sequence of transferrin receptor allow its translocation and membrane binding. Cell (1987) 1.76
Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J Virol (1994) 1.75
Expression of Semliki Forest virus proteins from cloned complementary DNA. II. The membrane-spanning glycoprotein E2 is transported to the cell surface without its normal cytoplasmic domain. J Cell Biol (1983) 1.70
Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol (1999) 1.69
Membrane proteins organize a symmetrical virus. EMBO J (2000) 1.67
Membrane-bound and secreted forms of penicillinase from Bacillus licheniformis. J Mol Biol (1978) 1.62
Reinitiation of translocation in the Semliki Forest virus structural polyprotein: identification of the signal for the E1 glycoprotein. EMBO J (1986) 1.60
Function of Semliki Forest virus E3 peptide in virus assembly: replacement of E3 with an artificial signal peptide abolishes spike heterodimerization and surface expression of E1. J Virol (1990) 1.57
Cross-linking of the spike glycoproteins in Semliki Forest virus with dimethylsuberimidate. Virology (1974) 1.52
Expression of the structural proteins of Semliki Forest virus from cloned cDNA microinjected into the nucleus of baby hamster kidney cells. Proc Natl Acad Sci U S A (1982) 1.50
The amphiphilic membrane glycoproteins of Semliki Forest virus are attached to the lipid bilayer by their COOH-terminal ends. J Mol Biol (1978) 1.49
Department of Biological Sciences, University of Warwick, Coventry, CV47AL, England. J Gen Virol (1974) 1.49
Expression of viral membrane proteins from cloned cDNA by microinjection into eukaryotic cell nuclei. Methods Enzymol (1983) 1.42
Assembly and entry mechanisms of Semliki Forest virus. Arch Virol Suppl (1994) 1.42
The signal sequence of the p62 protein of Semliki Forest virus is involved in initiation but not in completing chain translocation. J Cell Biol (1990) 1.38
Structure-function relation of the NH2-terminal domain of the Semliki Forest virus capsid protein. J Virol (1995) 1.38
Solubilization of the Semliki Forest virus membrane with sodium deoxycholate. Biochim Biophys Acta (1976) 1.37
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther (2004) 1.36
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) (2001) 1.35
Expression of heterologous proteins in cultured rat hippocampal neurons using the Semliki Forest virus vector. J Neurosci Res (1993) 1.34
Spike protein oligomerization control of Semliki Forest virus fusion. J Virol (1990) 1.34
The E2 signal sequence of rubella virus remains part of the capsid protein and confers membrane association in vitro. J Virol (1990) 1.34
Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut (2005) 1.33
Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J Virol (1998) 1.33
Glycosylation is not necessary for membrane insertion and cleavage of Semliki Forest virus membrane proteins. Nature (1978) 1.32
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. J Cell Biol (1996) 1.32
Membrane protein lateral interactions control Semliki Forest virus budding. EMBO J (1994) 1.31
Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine (1994) 1.30
Mutants of the membrane-binding region of Semliki Forest virus E2 protein. II. Topology and membrane binding. J Cell Biol (1986) 1.30
Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. J Cell Physiol (2005) 1.27
In vivo transfer of chromosomal mutations onto multicopy plasmids by transduction with bacteriophage P1. Gene (1985) 1.26
How an animal virus gets into and out of its host cell. Sci Am (1982) 1.26
The oligomerization reaction of the Semliki Forest virus membrane protein subunits. J Cell Biol (1995) 1.26
The 6-kilodalton membrane protein of Semliki Forest virus is involved in the budding process. J Virol (1995) 1.26
High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system. Eur J Biochem (1994) 1.25
Alteration of the cytoplasmic domain of the membrane-spanning glycoprotein p62 of Semliki Forest virus does not affect its polar distribution in established lines of Madin-Darby canine kidney cells. J Cell Biol (1986) 1.22
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci U S A (1995) 1.21
Mannosidase II and the 135-kDa Golgi-specific antigen recognized monoclonal antibody 53FC3 are the same dimeric protein. J Biol Chem (1990) 1.21
Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol (1992) 1.21
Multiple mechanisms for the inhibition of entry and uncoating of superinfecting Semliki Forest virus. Virology (1997) 1.21
Evidence for oestrogen receptor alpha-immunoreactivity in gonadotrophin-releasing hormone-expressing neurones. J Neuroendocrinol (1999) 1.20
Fate of the 6K membrane protein of Semliki Forest virus during virus assembly. Virology (1991) 1.20
The M1 and NP proteins of influenza A virus form homo- but not heterooligomeric complexes when coexpressed in BHK-21 cells. J Gen Virol (1998) 1.20
Role of cell surface spikes in alphavirus budding. J Virol (1992) 1.20
Preformed cytoplasmic nucleocapsids are not necessary for alphavirus budding. EMBO J (1996) 1.19
Nucleotide sequence of the melA gene, coding for alpha-galactosidase in Escherichia coli K-12. Nucleic Acids Res (1987) 1.18
Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res Hum Retroviruses (1997) 1.16
The first step: activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spike. J Mol Biol (1998) 1.16